keyword
Keywords Neonatal jaundice and immunogl...

Neonatal jaundice and immunoglobulin

https://read.qxmd.com/read/34235125/efficacy-of-intravenous-immunoglobulin-exchange-transfusion-therapy-on-gestational-alloimmune-liver-disease
#21
JOURNAL ARTICLE
Pai-Jui Yeh, Shiu-Feng Huang, Ming-Chou Chiang, Chao-Jan Wang, Ming-Wei Lai
Background: Gestational alloimmune liver disease (GALD) is a rare but critical cause of neonatal liver failure. After discovering the maternal-fetal alloimmune mechanism, intravenous immunoglobulin (IVIG) with or without exchange transfusion (ET) has gradually replaced antioxidant cocktails as the first-line therapy. Whether such therapy changes the outcome of neonates with GALD is yet to be defined. Method: We reported a pair of twins with discordant presentations, mild and self-limited in the older, whereas liver failure in the younger, who was successfully rescued by ET and IVIG...
2021: Frontiers in Pediatrics
https://read.qxmd.com/read/33936335/infants-affected-by-rh-sensitization-a-2-year-canadian-national-surveillance-study
#22
JOURNAL ARTICLE
Jillian M Baker, Douglas M Campbell, Katerina Pavenski, Aasha Gnanalingam, Kathleen Hollamby, Thivia Jegathesan, Alvin Zipursky, Vinod Bhutani, Michael Sgro
INTRODUCTION: Rh sensitization occurs when Rh(D)-negative women develop anti-Rh(D) antibodies following exposure through pregnancy or transfusion. Rh disease may cause jaundice, anemia, neurological impairment, and death. It is rare in countries where Rh Immune Globulin (RhIg) is used. Canadian Rh sensitization and disease rates are unknown. METHODS: This survey-based study was conducted using a Canadian Paediatric Surveillance Program questionnaire sent to Canadian paediatricians and paediatric subspecialists to solicit Rh disease cases from May 2016 to June 2018...
June 2021: Paediatrics & Child Health
https://read.qxmd.com/read/33898814/the-knowledge-of-indonesian-pediatric-residents-on-hyperbilirubinemia-management
#23
JOURNAL ARTICLE
Mahendra T A Sampurna, Rinawati Rohsiswatmo, Aris Primadi, Setya Wandita, Eko Sulistijono, Arend F Bos, Pieter J J Sauer, Christian V Hulzebos, Peter H Dijk
Hyperbilirubinemia in the newborn occurs more frequently in Indonesia. Therefore, it is important that pediatric residents in Indonesia acquire adequate knowledge of hyperbilirubinemia management. This study aims to determine the pediatric residents' knowledge on hyperbilirubinemia management, whether they follow recommended guidelines, and whether differences exist between five large Indonesian teaching hospitals. We handed out a 25-question questionnaire on hyperbilirubinemia management to pediatric residents at five teaching hospitals...
April 2021: Heliyon
https://read.qxmd.com/read/33585066/hemolysis-due-to-alpha-hemolytic-enterococcus-urinary-infection-a-rare-cause-of-early-and-severe-unconjugated-hyperbilirubinemia-in-a-neonate
#24
Birol Karabulut, Esin Alpagut Gafil
The reason for reporting this case is to remind that some microorganisms may cause hemolysis leading to early and severe hyperbilirubinemia by secreting hemolysin in cases; where bilirubin levels cannot be successfully decreased despite effective phototherapy, intravenous immunoglobulin, and even exchange transfusion, or in cases of increased rebound bilirubin (although urinary tract infection is associated with increased conjugated bilirubin fraction and prolonged jaundice). The most common causes of hemolysis are ABO/Rh incompatibility and enzyme deficiencies such as glucose-6-phosphate dehydrogenase (G6PDH), pyruvate kinase (PK), and galactose-1-phosphate uridyltransferase (GALT)...
March 2021: Journal of Pediatric Intensive Care
https://read.qxmd.com/read/33531772/neurological-manifestations-of-congenital-cytomegalovirus-infection-at-a-tertiary-care-centre-from-southern-india
#25
JOURNAL ARTICLE
Vykuntaraju K Gowda, Preeti Kulhalli, Dhananjaya K Vamyanmane
Background  Cytomegalovirus (CMV) is a ubiquitous herpes virus. It is the most common congenital viral infection. Data on congenital CMV in India are lacking and hence the present study was undertaken. Objectives  The aim of the study is to evaluate the clinical and radiological profile of neurological manifestations of congenital CMV infections in tertiary care hospital. Methods  This is a retrospective chart review of the clinical and laboratory profile of congenital CMV infections presenting from January 2018 to February 2020 to a tertiary care hospital in Southern India...
January 2021: Journal of Neurosciences in Rural Practice
https://read.qxmd.com/read/33159747/efficacy-of-newer-modalities-in-the-management-of-indirect-hyperbilirubinaemia-at-a-secondary-care-hospital-a-prospective-study-from-2015-2018
#26
JOURNAL ARTICLE
Muhammad Asad Farhan, Muhammad Imran Ali, Ali Faraz, Syed Yousaf Kazmi, Waqas Sami, Abdul Irfan
OBJECTIVE: To evaluate the efficacy of current practices and new modalities for the management of neonatal indirect hyperbilirubinaemia. METHODS: The prospective study was conducted at King Khalid Hospital, Al Majmaah, Saudi Arabia, from September 2015 to September 2018, and copmprised neonates with hyperbilirubinaemia who were managed using the National Institute for Health and Clinical Excellence 2010 guidelines. The outcomes were measured in terms of decrease in total serum bilirubin and clinical improvement...
October 2020: JPMA. the Journal of the Pakistan Medical Association
https://read.qxmd.com/read/33070152/-fenofibrate-as-an-adjuvant-to-phototherapy-in-pathological-unconjugated-hyperbilirubinemia-in-neonates-a-randomized-control-trial
#27
JOURNAL ARTICLE
Mohammad Hosny Awad, Sahar Amer, Mona Hafez, Islam Nour, AbdElaziz Shabaan
BACKGROUND: Despite widespread phototherapy usage, many new-born infants remain in need of other invasive lines of therapy, such as intravenous immunoglobulins and exchange transfusions. OBJECTIVE: Assessment of the efficacy and the safety of adding fenofibrate to phototherapy for the treatment of pathological jaundice in full-term infants. DESIGN/METHODS: We conducted a double blinded randomized control study on 180 full-term infants with pathological unconjugated hyperbilirubinemia admitted to the NICU at Mansoura University Children's Hospital...
April 2021: Journal of Perinatology: Official Journal of the California Perinatal Association
https://read.qxmd.com/read/31692740/hemolytic-anemia-caused-by-non-d-minor-blood-incompatibilities-in-a-newborn
#28
Ali Ulas Tugcu, Deniz Anuk Ince, Ozden Turan, Burcu Belen, Lale Olcay, Ayse Ecevit
Hyperbilirubinemia is one of the most widely seen cause of neonatal morbidity. Besides ABO and Rh isoimmunization, minor blood incompatibilities have been also been identified as the other causes of severe newborn jaundice. We report a newborn with indirect hyperbilirubinemia caused by minor blood group incompatibilities (P1, M, N, s and Duffy) whose hemolysis was successfully managed with intravenous immunoglobulin therapy. A thirty-two gestational weeks of preterm male baby became severely icteric on postnatal day 11, with a total bilirubin level of 14...
2019: Pan African Medical Journal
https://read.qxmd.com/read/29765787/liver-failure-and-conjugated-hyperbilirubinemia-in-a-preterm-neonate-role-of-early-ivig-and-exchange-transfusion
#29
Jayasree Nair, Vasantha H S Kumar
Neonatal liver failure (NLF) is a rare diagnosis but carries with it significant risks of mortality and morbidity. Common etiologies for NLF include metabolic causes, gestational alloimmune liver disease (GALD or neonatal hemochromatosis), and viral infections. We report a case of liver failure in a premature infant with abnormal iron profile within 48 hours of birth. Lack of accepted guidelines for the initial management of severe jaundice with a high direct component in the first week after birth made treatment challenging...
April 2018: American Journal of Perinatology Reports
https://read.qxmd.com/read/29551014/immunoglobulin-for-alloimmune-hemolytic-disease-in-neonates
#30
REVIEW
Carolien Zwiers, Mirjam Ea Scheffer-Rath, Enrico Lopriore, Masja de Haas, Helen G Liley
BACKGROUND: Exchange transfusion and phototherapy have traditionally been used to treat jaundice and avoid the associated neurological complications. Because of the risks and burdens of exchange transfusion, intravenous immunoglobulin (IVIg) has been suggested as an alternative therapy for alloimmune hemolytic disease of the newborn (HDN) to reduce the need for exchange transfusion. OBJECTIVES: To assess the effect and complications of IVIg in newborn infants with alloimmune HDN on the need for and number of exchange transfusions...
March 18, 2018: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/29474382/the-turkish-neonatal-jaundice-online-registry-a-national-root-cause-analysis
#31
MULTICENTER STUDY
Omer Erdeve, Emel Okulu, Ozgur Olukman, Dilek Ulubas, Gokhan Buyukkale, Fatma Narter, Gaffari Tunc, Begum Atasay, Nazli Dilay Gultekin, Saadet Arsan, Esin Koc
BACKGROUND: Neonatal jaundice (NNJ) is common, but few root cause analyses based on national quality registries have been performed. An online registry was established to estimate the incidence of NNJ in Turkey and to facilitate a root cause analysis of NNJ and its complications. METHODS: A multicenter prospective study was conducted on otherwise healthy newborns born at ≥35 weeks of gestation and hospitalized for only NNJ in 50 collaborator neonatal intensive care units across Turkey over a 1-year period...
2018: PloS One
https://read.qxmd.com/read/28397655/-liver-failure-in-neonatal-children-is-a-diagnostic-challenge
#32
Heidi Smedegaard, Vibeke Brix Christensen, Morten Hanefeld Dziegiel, Marianne Hørby Jørgensen
This case report presents a newborn boy with hypoglycaemia, anaemia, jaundice and severe coagulopathy during the first day of his life, imitating sepsis and disseminated intravascular coagulation. One week after the birth he was diagnosed with acute liver failure due to gestational alloimmune liver disease (GALD). Despite the fact that GALD is rare, it must be suspected in all unexplained stillborn children and infants with severe liver disease. If diagnosed, it is possible to prevent death and severe liver failure in future newborns by treating the affected women with immunoglobulin during pregnancy...
March 27, 2017: Ugeskrift for Laeger
https://read.qxmd.com/read/27459953/use-of-intravenous-immunoglobulin-in-neonates-at-a-tertiary-academic-hospital-a-retrospective-11-year-study
#33
JOURNAL ARTICLE
Lani Lieberman, Jordan Spradbrow, Amy Keir, Michael Dunn, Yulia Lin, Jeannie Callum
BACKGROUND: Intravenous immunoglobulin (IVIG) is used to treat a variety of diseases in the neonatal intensive care unit (NICU). Although audits have reported on the spectrum of IVIG use in adults, the indications and utilization in neonates has not been investigated. The objectives of this study were to describe the usage pattern of and indications for IVIG in a tertiary care NICU. STUDY DESIGN AND METHODS: A retrospective chart review was performed of all neonates who received IVIG in the NICU from January 2003 to December 2013...
November 2016: Transfusion
https://read.qxmd.com/read/26735259/a-novel-thyrotropin-releasing-hormone-receptor-missense-mutation-p81r-in-central-congenital-hypothyroidism
#34
JOURNAL ARTICLE
O Koulouri, A K Nicholas, E Schoenmakers, J Mokrosinski, F Lane, T Cole, J Kirk, I S Farooqi, V K Chatterjee, M Gurnell, N Schoenmakers
CONTEXT: Isolated central congenital hypothyroidism (CCH) is rare and evades diagnosis on TSH-based congenital hypothyroidism (CH) screening programs in the United Kingdom. Accordingly, genetic ascertainment facilitates diagnosis and treatment of familial cases. Recognized causes include TSH β subunit (TSHB) and Ig superfamily member 1 (IGSF1) mutations, with only two previous reports of biallelic, highly disruptive mutations in the TRH receptor (TRHR) gene. CASE DESCRIPTION: A female infant presenting with prolonged neonatal jaundice was found to have isolated CCH, with TSH of 2...
March 2016: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/26334436/anti-d-administration-in-pregnancy-for-preventing-rhesus-alloimmunisation
#35
REVIEW
Rosemary D McBain, Caroline A Crowther, Philippa Middleton
BACKGROUND: During pregnancy, a Rhesus negative (Rh-negative) woman may develop antibodies when her fetus is Rhesus positive (Rh-positive). These antibodies may harm Rh-positive babies. OBJECTIVES: To assess the effects of antenatal anti-D immunoglobulin on the incidence of Rhesus D alloimmunisation when given to Rh-negative women without anti-D antibodies. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2015) and reference lists of retrieved studies...
September 3, 2015: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/25899199/perforated-appendicitis-after-intravenous-immunoglobulin-therapy-in-a-term-neonate-with-haemolytic-jaundice
#36
JOURNAL ARTICLE
Basak Yildiz Atikan, Ozge Altun Koroglu, Mehmet Yalaz, Orkan Ergun, Zafer Dokumcu, Basak Doganavsargil, Mete Akisu, Nilgun Kultursay
Neonatal appendicitis is a rare clinical condition that may cause high morbidity and mortality if diagnosis is delayed. There is usually an underlying disease; it can also be a localized form of necrotizing enterocolitis. Here, we present a term neonate who was treated with intravenous immunoglobulin because of severe isoimmune hemolytic jaundice. The patient developed abdominal symptoms within 10 hours of therapy, was diagnosed with acute perforated appendicitis and completely recovered after surgery.
April 2015: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/25125032/-efficacy-and-safety-of-intravenous-immunoglobulins-in-the-management-of-neonatal-hyperbilirubinemia-due-to-abo-incompatibility-a-meta-analysis
#37
REVIEW
A Cortey, M Elzaabi, T Waegemans, B Roch, Y Aujard
OBJECTIVES: ABO fetomaternal red blood cell incompatibility (ABO FMI) induces an immune hemolysis after fetal transfer of hemolyzing maternal anti-A or anti-B. ABO hemolytic disease (ABO HD) remains the most frequent cause of severe and early jaundice in newborns. High levels of unconjugated hyperbilirubinemia may induce acute and chronic neurological complications. Severe hyperbilirubinemia can be prevented by first-line phototherapy (PT) treatment, but exchange transfusion (ET) is required if treatment is not effective, even if ET is linked with high hemodynamic, infectious, gastrointestinal, and/or biological morbidity...
September 2014: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
https://read.qxmd.com/read/24826985/clinically-significant-hemolytic-disease-of-the-newborn-secondary-to-passive-transfer-of-anti-d-from-maternal-rhig
#38
JOURNAL ARTICLE
Daniel N Cohen, Mary S Johnson, Wayne H Liang, Heather L McDaniel, Pampee P Young
BACKGROUND: RhIG is used worldwide to reduce the incidence of alloimmunization to D during pregnancy. We report a case of clinically significant neonatal hemolysis mediated by maternally administered RhIG. CASE REPORT: A 25-year-old, O-, primigravid mother with a negative antenatal antibody screen delivered a 6-lb 4-oz, blood group A, D+ baby girl at 36.5 weeks' gestation. Prenatal care included a dose of intramuscular RhIG at 28 weeks' gestation. At delivery, the newborn was markedly jaundiced with a total bilirubin of 6...
November 2014: Transfusion
https://read.qxmd.com/read/24810454/anti-m-antibodies-as-a-cause-of-intrauterine-fetal-death-and-neonatal-hyperbilirubinaemia
#39
JOURNAL ARTICLE
Deepak Sharma, Anuradha Murki, Srinivas Murki, Tejo Pratap
A preterm male infant (35 weeks), appropriate for gestational age with birth weight of 2.20 kg was born to a 28-year G2 P0 mother. The mother's blood group was A positive and the father's was B positive. Her first pregnancy was an intrauterine fetal death due to immune hydrops. The mother's blood was positive for indirect Coomb's test with 1:32 dilution and anti-M antibodies. This pregnancy was induced at 35 weeks of gestation. Investigations from the cord blood revealed A positive blood group, positive direct Coomb's test, haematocrit of 41...
2014: BMJ Case Reports
https://read.qxmd.com/read/24382531/neonatal-hyperbilirubinemia-due-to-abo-incompatibility-does-blood-group-matter
#40
JOURNAL ARTICLE
Sinem Akgül, Ayşe Korkmaz, Sule Yiğit, Murat Yurdakök
Newborn infants with maternal-fetal ABO incompatibility are at a greater risk for developing subsequent significant hyperbilirubinemia, and therefore, prediction of probable risk factors, such as the degree of hemolysis, gains importance. In this study, we aimed to evaluate the effect of fetal-neonatal blood group on the severity of hemolysis and jaundice due to maternal-fetal ABO incompatibility. In a retrospective analysis of 166 cases with ABO hemolytic disease of the newborn, risk factors for the severity of jaundice were compared in infants with blood group A or B...
September 2013: Turkish Journal of Pediatrics
keyword
keyword
99761
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.